The advantage of using these CFH related mouse models is the support for a role for complement activation in AMD pathogenesis comes from studies implicating variations in the CFH gene as the strongest genetic factor associated with risk for AMD [22, 23]. This evidence concerns the gene CFH and age-related macular degeneration.